FDA approves deep wrinkle filler

	Tweet

Inamed Corp. and Genzyme Corp. on Wednesday said the U.S. Food and Drug Administration has approved a larger-particle version of its injectable gel that can be used to temporarily fill the deepest facial wrinkles.

Called Hylaform Plus, the larger-particle version of hyaluronic acid-based wrinkle filler Hylaform was approved for treatment of moderate to severe facial wrinkles and folds.

Genzyme manufactures the products, while Inamed markets them.

The companies said the new product gives physicians in the U.S. a new, effective, nonsurgical tool to treat the deepest wrinkles and provide optimal facial contouring.

Inamed said Hylaform Plus enhances its product line to compete with rival filler Restylane in the U.S. market. Restylane is a hyaluronic acid filler sold by Medicis Pharmaceutical Corp.

Last year Inamed posted sales of more than $87 million in its facial aesthetics business, but the company warned in August that sales would decrease in the mid to high teens this year due to competition.

In addition to its line of wrinkle smoothers, the Santa Barbara, California-based company makes breast and facial implants and a device used to treat obesity.

Shares of Inamed closed up 9 cents at $47.65 on Nasdaq, while shares of Genzyme closed down $1.35 at $51.07.

RELATED STORIES:
Roche in talks with WHO to stockpile Tamiflu   Europe’s crisis spells more pain for drugmakers   Study: Few buy drugs online   Antidepressant shows early promise against bulimia   US FDA allows tracking tags on drug bottles   Experimental malaria vaccine shows early promise   Pfizer to offer medicine without meth ingredient   FDA Delays New Sunscreen Labeling Rules   New FDA report says earlier meetings w/FDA make drug review process more efficient   Doctors say release of Paxil data helps   FDA Warns of Changes in Infant Acetaminophen Dosage   Heart Risks Also Seen In Naproxen, Health Agency Says

Comments

[ + Post Your Own ]

Now you're in the public comment zone. What follows is not Armenian Medical Network's stuff; it comes from other people and we don't vouch for it. A reminder: By using this Web site you agree to accept our Terms of Service. Click here to read the Rules of Engagement.

There are no comments for this entry yet. [ + Comment here + ]